Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It is testing MRC Multicentre randomised controlled trial of cognitive behaviour therapy for Bipolarity.
In United Kingdom
This study is recruiting in the United States, in India, and in Serbia. It is testing lumateperone for depression in bipolarity.
Multiple locations, including DothanThis study is recruiting in the United States. It is testing LB-102 for Bipolarity.
Multiple locations, including Bentonville
This study is recruiting. It focuses on bipolarity and currently lists participation information in Canada.
In HamiltonThis study is recruiting. It focuses on depression and currently lists participation information in China.
In Nanjing
This study is recruiting. It focuses on depression and currently lists participation information in Poland.
In KrakowThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In BethesdaThis study is recruiting. It focuses on depression and currently lists participation information in France.
Multiple locations, including ParisThis study is recruiting. It focuses on bipolarity and currently lists participation information in Canada.
In TorontoThis study is recruiting. It focuses on bipolarity and currently lists participation information in France.
In CréteilThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In BronThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
In BethesdaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.